AC
Actuate Therapeutics Inc (ACTU)
NASDAQ·Healthcare·Biotechnology
$2.89
+1.40%
Mkt Cap $68.45M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 26, 2026 | — | — | — | -$0.24 | -$0.18 | +25.00% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.27 | -$0.25 | +7.41% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.19 | -$0.30 | -57.89% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.30 | -$0.32 | -6.67% | — | — |
| Q1 2025 Mar 13, 2025 | — | — | — | -$0.29 | -$0.33 | -13.79% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.55 | -$0.55 | +0.00% | — | — |
| Q3 2024 Sep 24, 2024 | — | — | — | — | -$4.20 | — | — | — |
| Q1 2024 Mar 31, 2024 | — | — | — | — | -$0.54 | — | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$0.50 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$0.41 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$0.39 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.39 | — | — | — |